Publications

  1. Okuno SH, Maran A, Robinson SI. Olaratumab for the treatment of advanced soft tissue sarcoma. Expert Rev Anticancer Ther. 2017 Oct; 17 (10):883-887 Epub 2017 Sept 08
    View PubMed
  2. Bravo D, Shogren KL, Zuo D, Wagner ER, Sarkar G, Yaszemski MJ, Maran A. 2-Methoxyestradiol-Mediated Induction of Frzb Contributes to Cell Death and Autophagy in MG63 Osteosarcoma Cells. J Cell Biochem. 2017 Jun; 118: (6)1497-1504.
    View PubMed
  3. Riester SM, Torres-Mora J, Dudakovic A, Camilleri ET, Wang W, Xu F, Thaler RR, Evans JM, Zwartbol R, Briaire-de Bruijn IH, Maran A, Folpe AL, Inwards CY, Rose PS, Shives TC, Yaszemski MJ, Sim FH, Deyle DR, Larson AN, Galindo MA, Cleven AGH, Oliveira AM, Cleton-Jansen AM, Bovee JVMG, van Wijnen AJ. Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcoma. J Orthop Res. 2017 May; 35 (5):1137-1146 Epub 2016 June 28
    View PubMed
  4. Mamo T, Mladek AC, Shogren KL, Gustafson C, Gupta SK, Riester SM, Maran A, Galindo M, van Wijnen AJ, Sarkaria JN, Yaszemski MJ. Inhibiting DNA-PKCS radiosensitizes human osteosarcoma cells. Biochem Biophys Res Commun. 2017 Apr 29; 486: (2)307-313.
    View PubMed
  5. Gustafson CT, Mamo T, Maran A, Yaszemski MJ. Molecular strategies for modulating Wnt signaling. Front Biosci (Landmark Ed). 2017 Jan 01; 22:137-156.
    View PubMed
  6. Gustafson CT, Mamo T, Shogren KL, Maran A, Yaszemski MJ. FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases. Front Pharmacol. 2017; 8:285.
    View PubMed
  7. Maran A, Yaszemski MJ, Kohut A, Voronov A. Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help? Materials (Basel). 2016 Jun 27; 9: (7).
    View PubMed
  8. Reumann S, Shogren KL, Yaszemski MJ, Maran A. Inhibition of Autophagy Increases 2-Methoxyestradiol-Induced Cytotoxicity in SW1353 Chondrosarcoma Cells. J Cell Biochem. 2016 Mar; 117: (3)751-9.
    View PubMed
  9. Maran A, Shogren KL, Yaszemski MJ. The estrogen metabolite 2-methoxyestradiol regulates eukaryotic initiation factor 4E (eIF4E) and inhibits protein synthesis in MG63 osteosarcoma cells Genes and Diseases. 2016; 3: (2)153-8.
  10. Kudina O, Shogren KL, Gustafson CT, Yaszemski MJ, Maran A, Voronov A. Invertible micellar polymer nanoassemblies target bone tumor cells but not normal osteoblast cells. Future Sci OA. 2015 Nov; 1: (3)FSO16.
    View PubMed
  11. Lu L, Arbit HM, Herrick JL, Segovis SG, Maran A, Yaszemski MJ. Tissue engineered constructs: perspectives on clinical translation. Ann Biomed Eng. 2015 Mar; 43: (3)796-804.
    View PubMed
  12. Maran A, Dadsetan M, Buenz CM, Shogren KL, Lu L, Yaszemski MJ. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells. J Biomed Mater Res A. 2013 Sep; 101(9):2491-9. Epub 2013 Jan 27.
    View PubMed
  13. van der Deen M, Taipaleenmaki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ, Ling L, Cool SM, Leong DT, Dierkes C, Zustin J, Salto-Tellez M, Ito Y, Bae SC, Zielenska M, Squire JA, Lian JB, Stein JL, Zambetti GP, Jones SN, Galindo M, Hesse E, Stein GS, van Wijnen AJ. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem. 2013 Jul 19; 288(29):21307-19. Epub 2013 May 29.
    View PubMed
  14. Yang C, Shogren KL, Goyal R, Bravo D, Yaszemski MJ, Maran A. RNA-dependent protein kinase is essential for 2-methoxyestradiol-induced autophagy in osteosarcoma cells. PLoS One. 2013; 8: (3)e59406.
    View PubMed
  15. Wang X, Krishnan C, Nguyen EP, Meyer KJ, Oliveira JL, Yang P, Yi ES, Erickson-Johnson MR, Yaszemski MJ, Maran A, Oliveira AM. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor. Hum Pathol. 2012 Nov; 43: (11)2047-52.
    View PubMed
  16. Wimbauer F, Yang C, Shogren KL, Zhang M, Goyal R, Riester SM, Yaszemski MJ, Maran A. Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells. BMC Cancer. 2012; 12:93.
    View PubMed
  17. Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma. Genes Chromosomes Cancer. 2011 Nov; 50: (11)849-58.
    View PubMed
  18. Demiralp B, Sarkar G, Okuno SH, Yaszemski MJ, Maran A. Osteosarcoma - an evaluation of current diagnosis, treatment and chemotherapy. European Musculoskeletal Review. 2011; 6(1):18-23.
  19. Kempen DH, Lu L, Hefferan TE, Creemers LB, Heijink A, Maran A, Dhert WJ, Yaszemski MJ. Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. Tissue Eng Part A. 2010 Dec; 16: (12)3769-77.
    View PubMed
  20. Benedikt MB, Mahlum EW, Shogren KL, Subramaniam M, Spelsberg TC, Yaszemski MJ, Maran A. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. J Cell Biochem. 2010 Apr 1; 109(5):950-6.
    View PubMed
  21. Dadsetan M, Szatkowski JP, Shogren KL, Yaszemski MJ, Maran A. Hydrogel-mediated DNA delivery confers estrogenic response in nonresponsive osteoblast cells. J Biomed Mater Res A. 2009 Dec 15; 91: (4)1170-7.
    View PubMed
  22. Halder C, Ossendorf C, Maran A, Yaszemski M, Bolander ME, Fuchs B, Sarkar G. Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma. Anticancer Res. 2009 Nov; 29: (11)4317-22.
    View PubMed
  23. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 2009 May; 30(14):2816-25. Epub 2009 Feb 20.
    View PubMed
  24. Yuan J, Ossendorf C, Szatkowski JP, Bronk JT, Maran A, Yaszemski M, Bolander ME, Sarkar G, Fuchs B. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest. 2009 May; 27(4):435-42.
    View PubMed
  25. Kempen DH, Yaszemski MJ, Heijink A, Hefferan TE, Creemers LB, Britson J, Maran A, Classic KL, Dhert WJ, Lu L. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. J Control Release. 2009 Mar 19; 134: (3)169-76.
    View PubMed
  26. Mandal D, Maran A, Yaszemski MJ, Bolander ME, Sarkar G. Cellular uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells. J Mater Sci Mater Med. 2009 Jan; 20: (1)347-50.
    View PubMed
  27. Lowry MB, Lotinun S, Leontovich AA, Zhang M, Maran A, Shogren KL, Palama BK, Marley K, Iwaniec UT, Turner RT. Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism. Endocrinology. 2008 Nov; 149(11):5735-46. Epub 2008 Jul 17.
    View PubMed
  28. Kempen DH, Lu L, Classic KL, Hefferan TE, Creemers LB, Maran A, Dhert WJ, Yaszemski MJ. Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants. J Control Release. 2008 Aug 25; 130: (1)15-21.
    View PubMed
  29. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials. 2008 Aug; 29: (22)3245-52.
    View PubMed
  30. Maran A, Shogren KL, Benedikt M, Sarkar G, Turner RT, Yaszemski MJ. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest. J Cell Biochem. 2008 Aug 01; 104: (5)1937-45.
    View PubMed
  31. Heine-Geldern A, Dadsetan M, Benedikt M, Gaustad D, Herrick J, Shogren KL, Maran A, Hefferan TE, Yaszemski MJ. Effect of dynamic flow on hydrogel-mediated phenotypic expression of human osteoblasts. 8th World Biomaterials Congress 2008. 2008; 3:1359.
  32. Heine-Geldern A, Dadsetan M, Yaszemski A, Ozgo K, Maran A, Hefferan TE, Yaszemski MJ. Incorporation of hydroxyapatite into hydrogels enhances differentiation of osteoblasts. 8th World Biomaterials Congress 2008. 2008; 3:1360.
  33. Kempen DHR, Lu L, Heijink A, Hefferan TE, Creemers LC, Maran A, Yaszemski MJ, Dhert WJA. The effect of sequential VEGF and BMP-2 release on ectopic and orthotopic bone regeneration. 8th World Biomaterials Congress 2008. 2008; 1:312.
  34. Fuchs B, Mahlum E, Halder C, Maran A, Yaszemski M, Bode B, Bolander M, Sarkar G. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene. 2007 Sep 15; 399: (2)137-43.
    View PubMed
  35. Mahlum E, Mandal D, Halder C, Maran A, Yaszemski MJ, Jenkins RB, Bolander ME, Sarkar G. Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells. Anal Biochem. 2007 Jun 15; 365(2):215-21. Epub 2007 Mar 24.
    View PubMed
  36. Mandal D, Srivastava A, Mahlum E, Desai D, Maran A, Yaszemski M, Jalal SM, Gitelis S, Bertoni F, Damron T, Irwin R, O'Connor M, Schwartz H, Bolander ME, Sarkar G. Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene. 2007 Jan 15; 386(1-2):131-8. Epub 2006 Sep 20
    View PubMed
  37. Shogren KL, Turner RT, Yaszemski MJ, Maran A. Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells. J Bone Miner Res. 2007 Jan; 22: (1)29-36.
    View PubMed
  38. Maran A, Gorny G, Oursler MJ, Zhang M, Shogren KL, Yaszemski MJ, Turner RT. 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. J Cell Biochem. 2006 Oct 1; 99(2):425-34.
    View PubMed
  39. Maran A, Shogren K, Zhang M, Yaszemski MJ, Hefferan TE, Spelsberg TC, Kloosterboer HJ, Turner RT. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone. Bone. 2006 Sep; 39(3):523-9. Epub 2006 May 16.
    View PubMed
  40. Kennedy AM, Shogren KL, Zhang M, Turner RT, Spelsberg TC, Maran A. 17beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity. Endocrinology. 2005 Jan; 146(1):201-7. Epub 2004 Oct 07.
    View PubMed
  41. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC, Turner RT. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone. 2002 Feb; 30(2):393-8.
    View PubMed
  42. Turner RT, Bolander ME, Sarkar G, An KN, Maran A, Ritman EL. An integrated approach to assess structure-to-function relationships in the skeleton. J Musculoskelet Neuronal Interact. 2001 Sep; 2(1):3-8.
    View PubMed
  43. Maran A, Zhang M, Spelsberg TC, Turner RT. The dose-response effects of ethanol on the human fetal osteoblastic cell line. J Bone Miner Res. 2001 Feb; 16(2):270-6.
    View PubMed
  44. Turner RT, Maran A, Lotinun S, Hefferan T, Evans GL, Zhang M, Sibonga JD. Animal models for osteoporosis. Rev Endocr Metab Disord. 2001 Jan; 2 (1):117-27
    View PubMed
  45. Turner RT, Kidder LS, Zhang M, Harris SA, Westerlind KC, Maran A, Wronski TJ. Estrogen has rapid tissue-specific effects on rat bone. J Appl Physiol (1985). 1999 Jun; 86(6):1950-8.
    View PubMed
  46. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats? Endocrinology. 1999 Jan; 140(1):50-4.
    View PubMed
  47. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is Resveratrol an Estrogen Agonist in Growing Rats?* *This work was supported by NIH Grant AA-11140 and the Mayo Foundation. Endocrinology. 1999 Jan 01; 140: (1)50-54.
    View PubMed